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The connective tissue adjacent to basal cell carcinomas 
(BCC) is frequently abnormal and contains increased 
numbers of fibroblasts and increased extractable colla-
genase. To d e termine whether BCC could produce these 
alterations by releasing mediators that regulated fibro-
blast function, we established BCC in culture and tested 
the ability of their culture supernatants to alter fibro-
blast proliferation and production of collagenase. Using 
tissue culture plates coated with type IV collagen and 
containing x-irradiated 3T3 feeder cells, we established 
epithelial colonies from 4 7 % of the BCC cultured. The 
BCC-derived colonies differed from normal epidermal 
cell colonies in their morphology, growth rate, and ker-
atin production. Culture supernatants from 4 out of 5 
confluent BCC-derived colonies contained factors that 
stimulated fibroblasts to proliferate and release colla-
genase. These findings show that BCC-derived epider-
mal cell colonies release mediators which alter fibro-
blast functions and suggest that some of the connective 
tissue changes associated with BCC in vivo are the result 
of BCC-fibroblast interactions. 
Neoplasms are frequently surrounded by an abnormal con -
nective t issue matrix [1] . The neoplasms may directly a lter 
adjacent connective tissue matrix by either producing connec-
tive tissue proteins [2,3 ] or proteolytic enzymes which degrade 
these proteins [4- 6]. Alternatively, neoplasms may indirectly 
alter adjacent connective tissue by regulating the function of 
stromal cells [7 ,8]. These alterations of the ext racellular matrix 
may play a critical role in the establishment, growth, and 
invasiveness of the tumor [9] . 
A number of connective tissue changes have been associated 
with basal cell carcinomas (BCC). The t issue adjacent to BCC 
characteristically has an increased number of fibroblasts and 
increased amounts of hyaluronic acid and extractable collagen-
ase [10]. The mechanisms underlying these connective tissue 
changes are unknown. Hashimoto et a! [11] have suggested 
that the increased collagenase activity is due to production of 
collagenase by the tumor. Bauer et al [12] have shown that 
fibrobl asts isolated from the connective tissue associated with 
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Abbreviations: 
BCC: basal cell carcinoma(s) 
DMEM: Dulbecco's minimal essential medium 
FCS: fetal calf serum 
HBSS: Hanks' balanced salt solution supplemented with 200 Uj 
ml penicillin, 200 ll/ ml streptomycin, and 2.5 ).Lg/ml ampho-
te ricin B 
HLF: human lung fetal fibroblasts 
IL-l : interleukin 1 
MEM: Eagle's minimum essential medium 
BCC produce more collagenase than do fibroblasts isolated 
from normal skin. They suggested that t he increased collagen -
ase activity observed in BCC was mediated by the tumor's 
ability to stimulate surrounding stromal cells to release colla-
genase. 
The purpose of the present investigation was to determine 
whether BCC released soluble mediators which regulate fibro -
blast functions. To achieve this, we established cultures from 
BCC and studied the effects of media collected from these 
cultures on fibroblasts in vitro. This report describes t he con-
ditions used to establish cultures of BCC, t he criteria used to 
identify that the cultures were of BCC origin, and a soluble 
factor(s) released by these cultures which stimulated fibroblasts 
to proliferate and release collagenase. 
MATERIALS AND METHODS 
Tissu.e 
Primary, nodular BCC were obtained from 32 patients who were 52-
81 years of age. The excised tumors were trimmed of normal -appearing 
skin and excessive connective tissue. A portion of each tumor was then 
examined histologically to confirm the diagnosis of a nodular BCC and 
to confirm that the tissue consisted primarily of tumor cells. Control 
epidermal cells were obtained primarily from abdominal skin removed 
at necropsy. Only tissue obtained in the first 8 h after death were used. 
Because BCC were obtained from sun-exposed skin, we also obtained 
epidermal cells from normal skin adjacent to nevi removed from sun-
exposed skin. No differences in morphology or growth were noted 
between colonies established from normal sun-exposed or sun-pro-
tected skin . 
Preparation of Epidermal Cell S uspensions 
After excision, BCC or normal skin was trimmed of excessive con-
nective tissue and washed extensively in Ca++_ and Mg++_free Hanks' 
balanced salt solution which had been supplemented with 200 U/ml 
penicillin, 200 llg/ml streptomycin, and 2.5 llg/ml amphotericin B 
(HBSS; Gibco, Grand Island, New York) . The tissue was then cut into 
small cubes (3 mm in length), placed in HBSS containing 0.25% t rypsin 
(Gibco) and 0.01% EDTA and incubated at 4"C overnight. The tissue 
was then pressed through a sterile wire mesh, the resulting cell suspen-
sion washed with HBSS and resuspended in Dulbecco's minimal essen-
tial medium (DMEM) supplemented with 10% fetal calf serum (FCS), 
4 mM L-glutamine, 20 mM HEPES, 100 U/ml penicillin, 100 llg/rnl 
streptomycin, and 2.5 llg/ml amphotericin B. Cell viability was deter-
mined by exclusion of 0.2% trypan blue. The cells were counted using 
a hemocytometer and their concentration adjusted for viability. The 
viability of BCC and normal epidermal cells ranged from 53- 75%. 
Coincu.bation of BCC-Deriued Cells with Fibroblas ts 
Human lung fetal fibroblasts (HLF) were obtained from the Ameri-
can Type Culture Collection (CCL-153, Bethesda, Maryland) and 
maintained in T-75 tissue culture fl asks (Falcon Plastic, Oxnard, 
California) using supplemented DMEM at 37"C in a humidified at-
mosphere containing 5% C0 2• Two days prior to use, the HLF were 
removed from their flasks by incubation in 0.25% trypsin for 10 min 
at 37"C. The HLF were then washed, counted, and suspended at 105 
cell/ ml in supplemented DMEM. Uncoated tissue culture wells (2.5 
cm2; Falcon) were seeded with 1 ml of the HLF suspension and 
incubation continued. For coculture, the media was then removed from 
the wells, and 1 ml of fresh DMEM containing 5 X 10" BCC-derived 
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cells was added. Cont rol cul tures consisted of wells wi thout HLF and 
we lls containing only HLF. Incubation was cont inued for 96 h, the 
medium was then removed from each well a nd passed through a 0.45-
J.LID filter to remove any remaining cells. This supernate was divided 
a nd tested for its int rinsic collagenase activ ity and its ability to stim-
u late fres h HLF to release collagenase. The latter was accomplished by 
dilu t ing the supernate 1:5 with fresh DMEM conta ining 0.1% lactoal-
bumin hyd rolysate instead of FCS and app lying t his conditioned me-
ilium to fresh subconfluent HLF. After 48 h of incubation, the medium 
from these cultures was co llected and tested for t he presence of colla-
genase. All cocul tures were performed in triplicate. 
Culture of BCC-Derived Cells 
Type IV collagen-coated tissue culture wells (2.5 cm2 surface area) 
were seeded with 5 X 105 BCC-derived cells or normal epidermal ce lls 
and 10'' x-irradiated (3000 r) 3T3 fibroblasts suspended in 1 ml of 
s upplemented DMEM. The cells were then incubated at 37"C in a 
humidified atmosphere containing 5% C0 2 • Fresh DMEM was added 
eve ry 3- 4 days, a nd t he cul tures inspected daily th rough an inverted 
phase-contrast microscope. 
T he type IV collagen used was extracted from human placentas and 
was a generous gift from Dr. Jerome Seyer (Connective T issue Labo-
ratory, VAMC, Memphis, T ennessee) . The type IV collagen was dis-
so lved in 0.1 % acet ic ac id at a co ncent ration of 100 11g/ml and 0.5 ml 
add ed to each well. Afte r 3 h at room temperature, the type IV collagen 
was removed, the wells rinsed with H BSS, and then used for the culture 
of e pidermal ce lls. 
3T3 fibroblasts were obtained from the American Type Culture 
Collect ion (CCL-92, Bethesda, Ma ryland) and maintained in flas ks 
under t he same condi t ions as described for HLF. Immediate ly prior to 
t h ei r use as feeder cells, they were x-irradiated (3000 r), removed from 
cul t ure by incubating them in 0.25% t rypsin, washed, and resuspended 
in DMEM at an appropriate concent ration. 
To determ ine whether epithelial ce ll cul tures released factors capable 
of stimulating fibroblasts to proliferate or release collagenase, t he 
cult ures were allowed to become conlluent. T hen, t he cultures were 
gen t ly washed with HBSS, and fresh DMEM was added to each well. 
This medium was collected after 3 days of incubation, passed through 
a .45-Jlm filter, and stored at 4 ·c un t il studied. 
CoLlagenase Assay 
Collagenolytic activity in cul ture supernatants was quantitated by a 
m o dified microassay previously desc ribed by Nagai et al [13]. Brief1 y, 
native type I calf skin collagen was radiolabeled with ["C]acetic an-
hydride by t he method of Caws ton and Barret [14] and kept in solut ion 
at 4 ·c at a concent ration of 2 mg/ ml in 0.01 M T ris/0.2 M NaCI, pH 
7.6, containing 0.02% Na azide. The "C- Iabeled collagen was dispensed 
in 50-111 aliquot.s into 400-Jll microfuge tubes, the tubes were t hen 
capped and allowed to sit overnight at 37"C to promote gel formation. 
Then 120 111 of the media to be tested was added to 100 11l 0.2 M Tris, 
0.015 M CaCh, 0.02 % Na azide at pH 7.6, and 30 1d of aminophenyl-
mecuric aceta te (tina! concent ration (0.001 M) was added to activate 
a n y latent co llagenase present in t he media. Th_esesamples were added 
to t he co llagen fibrill ar gel and incubated for 18 h at 37"C in a 
humidified atmosphere co ntaining 5% C0 2. T he assay was te rminated 
by centrifuging t he tubes at 10,000 rpm for 5 min, and 200-Jll aliquots 
were counted by a Beckman scintillat ion coun ter. For each assay, total 
counts released by 100% lysis of collagen gels were determined using 
bacterial collagenase. Background coun ts released by gels incubated 
with fresh media diluted with bu ffers were also determined. Collagenase 
activity for eac h sample was calculated as: 
Percent gel lys is 
-----~M~e~a~n~cp~m~~sa~t~n~p~le~-~m~e=a~n_c~p~tn~t~n~ed~t~·u_tn __ ~---
. X 100 Mean cpm bacte rial collagenase - mean cpm mediUm 
Fibroblast Proliferation Assay 
F ibroblast proliferation in response to epidermal cell -derived factors 
was tested as previously described by Postlethwaite and Ka ng [15]. 
Briefly, fibroblasts were grown in 150-mm glass petri dishes conta ining 
Eagle's minimum essential medium (MEM) supplemented with non-
essential amino ac ids, ascorbic ac id (50 Jlg/ml ), NaHC03 (pH 7.2) , 
pen icillin (100 U/ml), streptomycin (100 11g/ml), amphotericin B (1 
J.Lg/ml), and 10% heat-activated FCS. Fibroblasts used in proliferation 
assays were harvested from monolayer cul tures by t rypsinization , sus-
pended in MEM conta ining 10% FCS at a density of 5 X 10' cells/ ml , 
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and aliquots (0.5 ml) dispensed into Falcon multiwell plates (Falcon 
P lastics, #3003). The plates were incubated at 37"C in a humidified 
atmosphere conta ining 5% C0 2 for 16 h, at which time medium in each 
well was replaced with serum-free MEM (0.5 ml). Four hours later , 
medium was removed from each well and replaced with fresh serum -
free MEM (0.3 ml) and samples (0.2 ml) to be tested. Incubation was 
continued for 68 h at 37"C in a humidi fied atmosphere containing 5% 
C0 2 and then 1.0 11Ci of [3H]dThd (sp act 1.9 Ci/mmol, Schwarz/ 
Mann, Orangeburg, New York) in 25 11! was added to eacb well. Four 
hou rs late r, medium was aspirated, fibroblast monolayers washed 3 
times wit h 0.0075 M glycylglyc ine/0.14 M NaCl, pH 7.2, air-dried, and 
coated with clear lacquer. Well bottoms were removed from the p lates 
by using a punch, placed in scinti llation vials conta ining 10 ml Aquasol 
(New England Nuclear, Boston, Massachusetts) , and incorporated [3H] 
dThd quant itated in a scintillation counter. Final proliferation activity 
was expressed as the mean of quadruplicate determinations. 
Thymocyte Proliferation Assay 
T he presence of epidermal cell -derived thymocyte activating factor 
in culture supernatant was determined using a modification of the 
technique described by Luger et al [16]. Briefl y, mouse thymocytes 
were isolated, washed, and suspended in RPMI-1640 containing 2 mM 
L-glu tamine, 20 mM HEPES, 2 X 10-5 mM 2-mercaptoethanol, 100 U/ 
ml penicillin, 100 Jlg/streptomycin, and 15% heat-inactivated FCS at 
a concent ration of 7 X 106 cells/mi. One hundred microlite rs of the 
thymocyte suspension was seeded into individual wells of a 96-well 
t issue culture plate, and 50 11 ! of cul ture supernatant , fresh media, or 
in terleukin I (IL-1)-containing media was added to each well. The plate 
was t hen incubated at 37"C and 5% C02 for 72 h, pulsed with 0.8 11Ci 
of [3HJdThd (6.7 Ci/ mmol , New England Nuclear) for 6 hand the cells 
harvested onto fil ters and counted in a Beckman scintillation counter. 
Extraction and Separation of Keratins 
Keratins were extracted from BCC-derived cultures and normal 
epidermal cell cultures as desribed by Fuchs and Green [17] . Brief1y, 
the epi t helium from the cul tures was homogenized in 5 ml of 10 mM 
Tris-HCI (pH 7.6) containing 1 mM EDTA. The suspension was t hen 
cent rifuged at 8000 g and t he pellet washed with Tris-EDTA bu ffer 
and then with buffer containing 2% Nonidet-P40. T he keratins in t he 
fin al pe llet were dissolved in 1 ml of 2% sodium dodecyl sulfate and 10 
mM dithiothreitol at 37"C for 15 min with occasional sonication. The 
samples were then boiled for 2 min and cent rifuged to remove the 
insoluble residue. The keratins were separated by polyacrylamide gel 
electrophoresis on 8.5% slab gels using the technique described by l<ing 
and Laemmli [18]. M, standards were run with each ge l. The proteins 
were detected by staining with Coomassie Blue. 
Histology 
Confluent epidermal cell cultures were dissociated from their culture 
wells as an epithelial sheet by incubating t hem in Dispase (Sigma, St. 
Louis, Missouri) as previously described by Green et al [19]. The 
epithelial sheet was fixed in 10% buffered fo rmalin, embedded in 
paraffin, and l -11m sections cut vertically through the sheet. The 
sections were t hen stained with hematoxylin and eosin and examined. 
RESULTS 
Coincubation of BCC-Derived Cells with Fibroblasts 
To determine whether BCC interact wit h fibroblasts to pro-
duce t he a ltered connective t issue observed in vivo, we coincu-
bated BCC-derived cells wit h fibroblasts and tested t he culture 
supernatan t for collagenase activity and t he a bility to stimulate 
HLF to release collagenase. Supernatants from BCC-derived 
cells, fibroblasts, or their combination did n ot contain signifi-
can t collagenase activity (Table 1). The supernatants from 3 of 
5 BCC-fibroblast coincubation experimen ts, however, were able 
to induce a significan t increase in t h e amount of collagenase 
released by fibroblasts cult ured separately (Table 1). E levated 
levels of collagenase were not observed in t he supernatan ts of 
fibroblas t cult ures supported with either fresh media, super-
natants from BCC -derived cells a lone, or supernatan ts from 
fibrob last cult ures. These experiments suggested t hat BCC-
derived cells interacted with fibroblasts to induce t he re lease 
of a collagenase-stimulating factor. However, it was not clear 
which cells were responsible for re leasi n g t he factor. 
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TABLE I. The ability of different culture supernatants to stimulate 
fibroblast to release collagenase 
Collagenase activity 
ExperimcnL Source of Coll agenase activity by fibroblast grown 
supernatant of supernatant in culture 
supernatant 
BCC 2.1 a 2.9 
HLF 4.2 4.9 
BCC-HLF 3.1 29.5 
2 BCC 2.0 3.2 
HLF 3.4 4.7 
BCC-HLF 5.0 12.2 
3 BCC 2.0 5.0 
HLF 0.3 1.5 
BCC-HLF 1.3 23.2 
4 BCC 3.5 4.2 
HLF 4.0 3.8 
BCC-HLF 4.8 5.0 
5 BCC 5. 1 4.9 
HLF 3.1 2.9 
BCC-HLF 6.0 5.8 
"Percent collagen lysis. 
Examination of the wells from these experiments did not 
reveal recognizable epithelial colonies in either the wells seeded 
with BCC-derived cells or BCC-derived cells and fibroblasts. 
Because the BCC-derived cells were most likely heterogeneous, 
containing some fibroblasts and mononuclear cells, we could 
not exclude the possibility that cells other than those of BCC 
origin were responsible for our findings. To address this, we 
attempted to grow BCC in culture and test their ability to 
release fibroblast-stimulating factors. 
BCC-den:ued Epidermal Cell Cultures 
BCC-derived cells from 32 tumors were seeded onto plates 
coated with type IV collagen and containing x-irradiated 3T3 
cells. Fifteen tumors (47%) produced epithelial colonies, while 
17 failed to grow or became contaminated with bacteria or 
fungus within 3- 4 days of culture. Normal epidermal cell colo-
nies were established by an identical method but using cells 
from normal human skin. Normal epidermal cell colonies were 
successfully establi shed in 6 consecutive experiments. To as-
sure that BCC-derived colonies were indeed established from 
BCC cells rather than from any normal epidermal cells contam-
inating the BCC-derived cell preparations, the characteristics 
of the BCC-derived colonies were compared to normal epider-
mal cell colonies. 
Morphology 
BCC-derived cells formed colonies that were morphologically 
distinct from those of normal epidermal cells. At cont1uency, 
normal epidermal cell colonies were uniform with a "grainy" 
appearance under phase-contrast microscopy (Fig 1a) . Vertical 
histologic sections taken through cell layers from these cultures 
showed a well-defined basal cell layer surmounted by 4- 7 
keratinocytes (Fig 1b ). In contrast, conf1uent BCC-derived 
colonies lacked the "grainy" appearance, were irregular in size, 
and vacuolated (Fig 1c). Histologic sections of cell layers from 
these cultures showed a "sheet" composed of only 2-3 cells. 
The cells directly adjacent to the plastic tissue culture surface 
were inegularly arranged and shaped. These cells also con-
tained irregu lar nuclei (Fig 1d). 
Cell Growth Rate 
Several in vivo studies have confirmed the clinical observa-
tion that BCC are slow-growing tumors (20,21] . To determine 
whether the epithelial colonies derived from BCC differed in 
their growth rate from those derived from normal skin, we 
measured how long it took an equal number of BCC-derived or 
normal skin -derived cells to develop into colonies which cov-
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FIG 1. Comparison of epithelial colonies derived from BCC and 
normal skin. Cells from normal epidermis and BCC were grown in 2.5-
cm2 plastic tissue culture wells coated with type IV collagen and 
containing x-irradiated 3T3 fibroblasts. Normal epidermal cell cultures 
had a uniform appearance when viewed through a phase-contrast 
microscope (a). Histologic sections cut through the epidermal cetl 
culture in (a) show a multilayer epithelial sheet composed of 4- 7 cells 
which resembles epidermis in situ (b). BCC-derived colonies had many 
vacuolated cells under phase-contrast microscopy (c). Histologic sec-
tions cut through the culture in (c) show a 2-4 cell layer epithelium 
with irregular shaped, vacuolated cells (d). 
TABLE ll. Growth rate of epithelial cell colonies 
Percent of well 
covered 
25% 
50- 75% 
100% 
Day of culture 
Basal cell carcinomas 
8-14 (15/15)" 
12-32 (9/ 15) 
17- 28 (6/ 15) 
Normal epidermal cells 
1- 2 (6/6) 
3- 6 (6/ 6) 
7- 10 (6/ 6) 
a (Positive cultures/total cultured). 
ered 25%, 50-75%, and 100% of the tissue culture well's surface. 
Before estimating the area covered by the colonies, the fibro -
blasts used as feeder cells were removed with trypsin . Table II 
shows that all the normal epidermal cell cultures became con-
f1uent by 7- 10 days. In contrast, cultures from only 6 of 15 
BCC (40%) became conf1uent and required 17-28 days to do 
so. Additionally, fewer mitotic figures were observed in BCC-
derived culture than in normal epidermal cell cultures (data 
not shown). 
Keratin 
BCC in vivo fail to produce the high-Mr (67K) keratins 
produced by normal epidermis [22,23]. Furthermore, normal 
epidermal cells in vitro will produce 67K keratins when grown 
in delipidized FCS, but not when grown in whole FCS (17]. To 
determine whether BCC-derived cultures were deficient in 
67K keratins, we cultured the BCC in whole and delipidized 
FCS. The keratins were extnicted from BCC-derived colonies 
and their Mr determined by polyacrylamide gel electrophoresis. 
Fig 2 shows that BCC-derived cultures grown in either whole 
or delipidized serum fai l to produce 67K keratins. Control 
cultures of normal epithelial cells, grown in delipidized serum, 
produced detectable levels of 67K keratins (Fig 3). BCC-derived 
cultures, thus, resemble BCC in vivo in their morphology, 
growth rate, and keratin production. 
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FIG 2. Keratins produced by BCC in cultu re. BCC-derived cultures, 
which were grown in whole or del ipidized FCS, were allowed to become 
confluent, removed from their culture wells using Dispase, and their 
keratins extracted. The keratins were then separated by polyacrylamide 
gel electrophoresis on an 8.5% gel slab and the proteins stained with 
Coomassie Blue. Lane I shows the M, standa rds run concurrently with 
the keratins extracted from BCC grown in whole FCS (lan e 2) or grown 
in delipidized FCS {lane 3). Although neither of the BCC cultures 
produced 67K M, keratins, both cultures produced sim ilar lower-M, 
keratins. 
67K ~ 
45K ~ 
2 3 
FIG 3. Normal skin -derived epidermal cells were grown in whole or 
delipidized FCS, allowed to become confluent, and their keratins ex-
tracted. The keratins were then separated by polyacrylamide gel elec-
trop horesis as previously described. Lane 1 shows theM, standards run 
concurrently with the extracted keratins. Lane 2 shows the M, of 
keratins from cul tures grown in whole FCS. No 67K keratins are seen. 
Lane 3 shows the keratins extracted from cultures grown in delipidized 
FCS. The M, of these keratins are similar to those in Lane 2, but also 
contain 67K keratins. 
Factors in BCC-Derived Culture Supernatants Alter Fibroblast 
Function 
Culture supernatants from 4 out of 5 confluent BCC-derived 
colonies stimulated incorporation of [3H]dThd and release of 
collagenase by fibroblasts. These culture supernatants also 
stimulated thymocyte proliferation. In contrast, supernatants 
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TABLE III. The ability of different culture supernatants to regulate 
fibroblast and thymocyte function 
Fibroblast Fibroblast Thymocyte 
Source of supernatant collagenase activity proliferation proliferation (['H]dThd ([ 3H]dThd (% collagen lysis) incorporation) incorporation) 
Basal cell carcino- 23.1 1001 ± 162b 2872 ± 156 
mas a 
Normal epidermal 4.5 388 ± 19 101 ± 19 
cells" 
Lipopolysaccharide ND ' 1563 ± 168 5315 ± 82 
stimulated human 
blood cells (inter-
leukin-1) 
Fresh medium 3.8 158 ± 12 85 ± 10 
a Confluent cultures. 
bMean ± SEM. 
' Not done. 
from confluent normal epidermal cell cultures failed to stimu-
late either fibroblast or thymocyte proliferation (Table III). 
Regulatory factors were not identified in one of the BCC-
derived colonies. This colony contained cells morphologically 
and quantitatively similar to other BCC-derived cultures. Me-
dium containing IL-l was used as a positive control for stimu-
lating fibroblast and thymocyte proliferation. The BCC-derived 
culture supernatants produced a fibroblast or thymocyte prolif-
erative response that was 59- 70% and 50-62%, respectively, of 
that produced by IL-l-containing medium. 
DISCUSSION 
Epithelial-mesenchymal interactions are known to play a 
key role in a variety of physiologic events. Most studies have 
focused on the mesenchyme's ability to affect the overlying 
epithelium. A few studies have begun to investigate the ability 
of the epithelium to regulate its adjacent mesenchyme [7,8]. 
The present study has investigated the ability of BCC-derived 
colonies to release a factor(s) that regulates fibroblast functions 
and thereby mediates the mesenchymal changes associated with 
BCC in vivo. Our initial experiments showed that supernatants 
from BCC-derived cells incubated with fibroblasts, could stim-
ulate freshly cultured fibroblasts to release collagenase, whereas 
supernatants from BCC-derived cells or fibroblasts incubated 
alone could not. It was not clear from these experiments why 
the fibroblast collagenase-stimulating factor present in the 
supernatants obtained from BCC-fibroblast coincubations did 
not stimulate the fibroblasts coincubated with BCC-derived 
cells to release collagenase. Several factors may explain this 
seemingly incongruous finding. The ability of fibroblasts to 
produce collagenase is enhanced primarily during the log-phase 
growth and diminish as the fibroblasts become confluent [24]. 
Differences in the duration of the incubation in coincubated 
fibroblasts vs freshly incubated fibroblasts (96 h vs 48 h) placed 
the freshly cultured fibroblasts in a more favorable condition 
to respond to the collagenase-stimulating factor. Alternatively, 
the collagenase produced by fibroblasts coincubated with BCC-
derived cells may have been inactivated by anti protease present 
in 10% FCS [25 ,26]. Because the supernatants were diluted 
with serum-free medium before being used to stimulate freshly 
seeded fibroblasts, the residual FCS may not have been able to 
totally inactivate the newly released collagenase. Alternatively, 
the culture supernatants in the initial cultures may have had 
their collagenase inhibited by known antiproteases present in 
10% FCS serum [25,26]. Because the coculture supernatants 
were diluted 1:5 in serum-free medium and then tested for their 
ability to stimulate collagenase, the residual FCS serum may 
not have been able to inactivate the newly released collagenase. 
The experimental design of our initial coculture studies did 
not allow us to determine whether BCC-derived cells, fibro-
blasts, or both were secreting the collagenase-stimulating fac -
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tor. To determine whether the BCC-derived cells released the 
collagenase-stimulating factor, it was necessary to establish 
BCC-derived cells in culture and show that these cell s, in the 
absence of fibroblasts, released factors that could alter fibro-
blast behavior. Previous investigators have reported difficulties 
in establishing BCC in culture. Kubilus eta] [23] established 
cultures using BCC on ly when cholera toxin was added to their 
culture sytem. Even with cholera toxin in their culture system, 
they were able to culture only a small percentage of the tumors 
seeded. To faci litate our chances of growing BCC in culture we 
decided to change the culture conditions to favor the attach-
ment and growth of BCC. Stanley et al (27) has previously 
reported that basal cells preferentially adhered to type IV 
co llagen. We, therefore, coated our cultllre dishes with type IV 
collagen in an attempt to enhance attachment and growth of 
BCC-derived cells. In addition, we included x-irradiated 3T3 
cells in the cultures which have been shown to enhance epider-
mal cell growth in vitro [28). Cholera toxin and other growth 
stimulants were not added. With our culture system, 4'7 % of 
the tumors seeded were established in culture and a number of 
failures could be attributed to bacterial or fungal contamina-
tion. The BCC-derived colonies were distinctly different from 
epithelial colonies derived from normal skin in their morphol-
ogy, growth rate, and in their production of keratins, but 
retained some similarities to BCC. BCC-derived cultures 
showed morphology, growth, and a keratin expression pattern 
which were distinctly different from normal epidermal cell 
cultures. 
Clinically, BCC are slow-growing tumors. This clinical ob-
servation has been confirmed experimentally. Terz et al [20) 
demonstrated "resting areas" within the tumor mass by using 
autoradiographic techniques. Heenen and Galand (21) docu-
mented a prolonged S-phase in the tumors' cell cycle. Our 
findings that BCC-derived colonies require 10- 18 days more 
than normal epidermal cell colonies to cover the culture surface 
and that on ly 40% of tumors become confluent support the 
observations that BCC-derived colonies retain a growth rate 
compatible with the tumor's in vivo growth. This finding differs 
from that reported by Kubilus et a! (23] that the growth rate 
of the BCC cultures was s'milar to that of normal epidermal 
cell cultures. It is possibh that the cholera toxin which was 
used to stimulate epidermal cell growth in their culture system 
may also account for the differences. 
BCC in vivo, unlike normal epidermis, fails to produce 67K 
M, keratins [22]. Both normal epidermal cell cultures and BCC-
derived cultures grown in whole FCS fai l to produce 67K 
keratins [17,22]. Fuchs and Green [17] reported that normal 
epidermal cells grown in FCS, from which the vitamin A had 
been removed by extracting the lipids, caused normal epidermal 
cell cultures to produce 67K keratins. We used whole and 
delipidized FCS to determine whether BCC-derived cultures 
were capable of producing 67K keratins. Our findings show 
that BCC-derived cultures did not change their pattern of 
keratin formation regardless of whether they were grown in 
whole or delipidized FCS. These findings further suggest that 
our BCC-derived cultures retained characteristics similar to 
BCC in vivo. 
Bauer et al [29) showed by immunot1uorescence that colla-
genase was localized in the connective tissue stroma surround-
ing BCC and not in the BCC. They also showed that fibroblasts 
from the connective tissue adjacent to BCC produced higher 
levels of collagenase than those isolated from normal skin 
[12) . However, as the fibroblasts from the tissue adjacent to 
BCC were subcultured their ability to release collagenase di-
minished. These findings led them to suggest that BCC influ-
enced fibroblast release of collagenase. Our study showed that 
confluent epithelial colonies derived from BCC but not those 
derived from normal skin, released a soluble fa~tor(s) capable 
of stimulating fibroblast cultures to release collagenase and 
proliferate. Since the 3T3 fibroblasts used to help establish the 
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epithelial colonies were removed prior to collecting the culture 
supernatants, the BCC-derived cells produced and released the 
fibroblast regulatory factors. Whether BCC-derived cells must 
interact with fibroblasts in order to release their regulatory 
factors, as suggested by initial coincubation experiments, could 
not be excluded because fibroblasts were used to establish all 
the epithelial cultures. Our in vitro findings suggest that BCC 
in vivo may aberrantly release factors capable of altering fibro-
blasts' ·functions, resulting in the abnormal connective tissue 
associated with BCC. 
The BCC-derived factor discovered in the present study has 
not yet been characterized. It seems reasonable to suggest that 
this factor is similar to that reported in several other studies. 
Goslen et al [30) reported that extracts from BCC dissected 
away from its connective tissue contained a factor that stimu-
lated fibroblasts to release collagenase. Johnson-Wint and 
Gross [31] reported that rabbit epidermal cells released a 55,000 
and 30,000 M, factor that could stimulate fibroblasts to release 
collagenase. These investigators had previously shown that the 
release of factors stimulating or inhibiting collagenase was 
dependent on epidermal cell densities [32). Luger et al [33] 
demonstrated a cell density-dependent release of an IL-l-like 
mediator from epidermal cells. This factor or one that coelutes 
with it chromatographically was found to stimulate fibroblast 
and thymocyte proliferation [34). These findings coupled with 
ours suggest that BCC in vivo may regulate fibroblast functions 
through the aberrant release of an IL-l-like mediator. This 
possibility is particularly attractive because IL-l has been 
shown to increase fibroblast proliferation [15,35] and increase 
fibroblast production of both collagenase [36] and hyaluronic 
acid [37]. Consequently, most of the connective tissue changes 
associated with BCC in vivo could be attributed to the tumors' 
aberrant release of an IL-l-like mediator. 
Several studies have suggested that the development, growth, 
and invasiveness of BCC or other neoplasm is facilitated by 
the abnormal connective tissue adjacent to the tumor [9] . Our 
findings suggest that the BCC mediate some of the changes in 
its adjacent connective tissue matrix. However, many of the 
abnormal connective tissue changes associated with BCC can 
be seen prior to the development of the tumor. These changes 
frequently occur in sun-exposed areas and have been termed 
"actinic damage." Recent studies have shown that ultraviolet 
radiation stimulates the release of an IL-l-like mediator by 
epidermal cells in vivo and in vitro [38). The increased release 
of such a mediator in sun-exposed skin may stimulate fibro-
blasts to produce hyaluronic acid and other connective tissue 
changes observed with actinic damage. Thus, actinic damage 
may be mediated directly by ultraviolet radiation's effect on 
the connective tissue matrix, or indirectly by its effect on 
epidermal cell release of fibroblast regulatory factors. The 
actinically damaged connective tissue may then provide an 
adequate environment for the induction, growth, and invasive-
ness of BCC. Once the BCC has established itself, it may 
continue to provide for its own environment by aberrantly 
releasing factors that regulate fibroblast behavior. Further 
studies are needed to elucidate the epithelial-mesenchymal 
interactions which may play a fundamental role in the biology 
of cutaneous neoplasms. 
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